Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.
Sophia Shaklian, 38, of Los Angeles, and accomplices bilked Medicare of millions by submitting false claims for diagnostic imaging and hospice care that was unnecessary or never administered.
In a Final Rule revealed last week, the Centers for Medicare & Medicaid Services outlined its plan to exchange medical records, diagnostic images and clinical notes electronically using secure protocols. Once published in the Federal Register, any HIPAA-covered entity that interacts with Medicare will have two years to follow CMS into the modern age.
ImmunityBio, the developer of bladder cancer treatment Anktiva, is accused by the U.S. Food and Drug Administration of disseminating “false or misleading information” about the drug's efficacy in an advertisement and podcast. The FDA said it’s not the first time it's sent a warning letter to executives over allegedly inaccurate claims.
“Our dedicated team is working diligently to minimize wait times and ensure patients receive the best possible care," Jefferson Radiology said in a statement shared Wednesday.
Intensive care units around the world use daily diaries to track patients’ emotional as well as physical ups and downs. Many find that keeping these helpful resources can add to nurses’ already-heavy workloads. How might generative AI help?
Luigi Mangione, 26, has been officially charged with the murder of UnitedHealthcare CEO Brian Thompson. He awaits extradition to New York after being arrested in Pennsylvania, where he was found carrying a gun, fake IDs and a handwritten document.
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.
